Professional Documents
Culture Documents
11/15/15
www.apollohospitals.com
SAFEHARBOUR
Contents
HIGHLIGHTS
STANDALONE
FINANCIAL
PERFORMANCE
11/15/15
www.apollohospitals.com
CONSOLIDATED
FINANCIAL
PERFORMANCE
OPERATIONAL
PERFORMANCE
HOSPITALS
OPERATIONAL
PERFORMANCE
STANDALONE
PHARMACY
UPDATEON
PROJECTS
UPDATEON
NONHOSPITAL
JVS
HIGHLIGHTS
11/15/15
www.apollohospitals.com
Highlights
1of2
Financial
Performance
Chennai cluster displayed 13.2% increase in revenues in H1 FY16 at ` 6,866 mio as compared to ` 6,063 mio in H1 FY 15.
Hyderabad Revenues grew by 7.1% in H1 FY16 to ` 2,618 mio as compared to ` 2,445 mio in H1 FY15. However ARPOB
registered a healthy 15% growth due to case mix improvement and reduction in Low Yielding cases.
New Hospitals displayed good growth. Revenues grew from ` 767 mio in H1FY15 to ` 1,407 in H1FY16.Vanagaram & Jayanagar
have moved into positive EBITDA trajectory.
Bangalore region including Mysore have displayed a healthy revenue growth of 22%
11/15/15
www.apollohospitals.com
Key
Operational
Highlights
Stand Alone Pharmacies (SAP) reported Revenues of ` 11,032 mio, growth of 34%. SAP EBITDA at ` 403 mio (3.7% margin) in H1
FY16 .
Apollo Munich achieved a Gross Written Premium of ` 4,051 mio in H1 FY16 against ` 3,001 mio achieved during the same
period in the previous year representing a growth of 35%.
Highlights
2of2
Capacity
64 hospitals with total bed capacity of 8,985 beds as on Sep 30, 2015
40 owned hospitals including JVs/ Subsidiaries and Associates with 7,123 beds
11 Day care/ short surgical stay centres with 306 beds and 5 Cradles with 122 beds
8 Managed hospitals with 1,434 beds.
Of the 7,123 owned hospital beds capacity, 6,368 beds were operational and had an occupancy of 67%.
The total number of pharmacies as on Sep 30, 2015 was 2,217. Gross additions of 117 stores with 21 stores closures thereby
adding 96 stores on a net basis.
Medical
Initiatives
Accomplish
ments
Apollo Hospitals in Chennai successfully completes Asia's first enbloc combined heart and liver transplant
A team of Apollo doctors have successfully performed a complex pediatric liver transplant surgery on a 4year old child suffering
from a rare metabolic disorder.
Apollo Hospital, Madurai performed a rare surgery on a 15yearold boy by using endoscopy for excision of a vascular tumour in an
inaccessible area thereby sparing him of a permanent scar on his face by avoiding open surgery. The boy was discharged in three
days under this method against a hospitalization of at least 2 weeks under the conventional method.
The Government launched a health service called SEHAT (Social Endeavour for Health And Telemedicine) along with Apollo
Hospitals, which will connect 60,000 Common Service Centers (CSCs) across the country to a common network. This will greatly
improve the healthcare access to millions of citizens as they can visit a Common Service Centers (CSC) and fix an appointment for
seeking expert consultancy from doctors at Apollo Hospitals.
OtherKey
Developments
11/15/15
www.apollohospitals.com
Apollo Health City, Hyderabad, has been adjudged as the 'Best Medical Tourism Facility in India by the Government of India, for
the year 201314. This is the third time that the facility has won this award; having been conferred the award in the years 2009
2010 and 20112012 earlier.
Awarded the prestigious Porter Prize for Value Based Healthcare in recognition of its efforts towards redefining healthcare,
providing an overall framework for diagnostics, participating in building a resilient health care system, focusing on providing
value to patients and innovation in healthcare such as enhancing the patients experience.
STANDALONE
FINANCIALPERFORMANCE
11/15/15
www.apollohospitals.com
StandaloneFinancialPerformance Total
Revenue
OperativeExpenses
EmployeeExpenses
Administrative&OtherExpenses
TotalExpenses
EBITDA
margin(%)
Depreciation
EBIT
margin(%)
FinancialExpenses
OtherIncome
ProfitBeforeTax
ProfitAfterTax
margin(%)
ROCE(Annualized)(1)
CapitalEmployed
(1)
Q2FY15
11,529
6,088
1,795
1,920
9,803
1,726
15.0%
388
1,337
11.6%
201
82
1,218
915
7.9%
Q2FY16
13,673
7,326
2,047
2,368
11,742
1,932
14.1%
462
1,470
10.7%
309
45
1,206
937
6.9%
yoy(%)
18.6%
20.3%
14.1%
23.3%
19.8%
11.9%
84bps
18.9%
9.9%
85bps
53.2%
45.5%
1.0%
2.4%
109bps
(` mio)
H1FY15
22,066
11,620
3,502
3,655
18,777
3,289
14.9%
788
2,501
11.3%
391
147
2,257
1,742
7.9%
H1FY16
26,323
14,051
3,979
4,551
22,581
3,742
14.2%
912
2,830
10.8%
577
87
2,340
1,845
7.0%
14.0%
35,831
12.8%
44,205
yoy(%)
19.3%
20.9%
13.6%
24.5%
20.3%
13.8%
69bps
15.8%
13.2%
58bps
47.7%
40.9%
3.7%
5.9%
89bps
KeyHighlights
H1FY16Revenuesof` 26,323mio,
19.3%yoygrowth
H1FY16EBITDAat` 3,742mio,
13.8%yoygrowth
H1FY16EBITat ` 2,830mio,
13.2%yoygrowth
H1FY16PATat ` 1,845mio,
5.9%yoygrowth
11/15/15
www.apollohospitals.com
1of3
StandaloneFinancialPerformance Existing&NewBreakup
H1FY16
H1FY15
YOYGrowth
RevenueGrowth
EBITDARGrowth
EBITDAGrowth
EBITGrowth
Healthcare
Service
New
(Existing) Hospitals
Revenue
13,884
1,407
EBITDAR
3,638
77
margin(%)
26.2%
5.5%
EBITDA
3,383
44
margin(%)
24.4%
EBIT
2,770
247
margin(%)
20.0%
Revenue
13,064
767
EBITDAR
3,298
26
margin(%)
25.2%
3.3%
EBITDA
3,066
40
margin(%)
23.5%
EBIT
2,474
142
margin(%)
18.9%
11/15/15
www.apollohospitals.com
6.3%
10.3%
10.4%
12.0%
83.4%
202.1%
Healthcare
Services
(Total)
15,291
3,716
24.3%
3,339
21.8%
2,524
16.5%
13,832
3,323
24.0%
3,026
21.9%
2,333
16.9%
SAP
Standalone
11,032
766
6.9%
403
3.7%
306
2.8%
8,234
523
6.4%
263
3.2%
168
2.0%
26,323
4,481
17.0%
3,742
14.2%
2,830
10.8%
22,066
3,847
17.4%
3,289
14.9%
2,501
11.3%
10.6%
11.8%
10.4%
8.2%
34.0%
46.2%
53.2%
82.0%
19.3%
16.5%
13.8%
13.2%
(` mio)
KeyHighlights
HealthCareServicesrevenuegrowth
at10.6%from` 13,832mioinH1FY
15to ` 15,291mioinH1FY16
NewHospitalsrevenuesgrew83.4%
fromRs767mioinH1FY15toRs
1,407mioinH1FY16
ExistingHealthCareServicesrevenues
grew6.3%whileEBITDAmargins
increasedby90bpsfrom23.5%inH1FY
15to24.4%inH1FY16.
FY13Hospitals Vanagaram&
JayanagarreportedanEBITDAof
` 86mioinH1FY16.
FY14/FY15hospitals Trichy,Nashik,
Women&Child OMR,Nellore,
Perungudi,Women&Child SMRhave
anEBITDAlossof ` 130mio.
2of3
StandaloneFinancialPerformance SegmentReporting
Revenuesfromeachsegment
HealthcareServices*
StandalonePharmacy
OtherIncome
Total
Less:IntersegmentalRevenue
NetRevenues(incl.otherincome)
ProfitbeforeTax&Interest(EBIT)
HealthcareServices*
StandalonePharmacy
OtherIncome
TotalEBIT(incl.otherincome)
ProfitbeforeTax&Interest(EBIT)margins
HealthcareServices*
StandalonePharmacy
TotalEBITmargin(incl.otherincome)
InterestExpense
ProfitBeforeTax
CapitalEmployedHealthcareservices(1)
Healthcareservices ROCE(Annualized)
(` mio)
Q2FY15
Q2FY16
yoy(%)
H1FY15
H1FY16
yoy(%)
7,158
4,372
82
11,611
1
11,611
7,844
5,831
45
13,719
1
13,718
9.6%
33.4%
45.5%
18.2%
15,294
11,032
87
26,412
2
26,410
10.6%
34.0%
40.9%
18.9%
18.2%
13,834
8,234
147
22,214
2
22,212
1,241
96
82
1,419
1,305
164
45
1,514
5.2%
71.3%
45.5%
6.7%
2,333
168
147
2,647
2,524
306
87
2,917
8.2%
82.0%
40.9%
10.2%
17.3%
2.2%
12.2%
201
1,218
16.6%
2.8%
11.0%
308
1,206
119bps
53.2%
1.0%
16.9%
2.0%
11.9%
391
2,257
31,203
15.0%
16.5%
2.8%
11.0%
577
2,340
38,205
13.2%
88bps
47.7%
3.7%
KeyHighlights
HealthcareservicesRevenuesat
` 15,294mio,growthof10.6%
StandalonepharmaciesRevenues
at` 11,032mio,growthof34.0%.
18.9%
NewHospitals(Vanagaram,Jayanagar,
Trichy,Nasik,Women&Child OMR,
Nellore,Perungudi,Women&Child
SMR)havingcapitalemployedof
` 9,156mioyettocontributetoROCE.
ExistinghealthcareservicesRoCE
wasat19.1%inH1FY16as
comparedto18.6%inH1FY15
*HealthcareServicesconsistsofHospitals,HospitalBasedPharmaciesandConsulting
(1) Capital employed for the calculation of ROCE does not include Capital Work in progress on new hospital expansion projects of ` 7,461 mio for H1 FY 16 and ` 6,197 mio for H1 FY 15 & investments in mutual funds and associates.
Previous year figures have been reworked/regrouped/rearranged and reclassified wherever necessary to conform to the requirement of revised Schedule VI format
10
11/15/15
www.apollohospitals.com
3of3
10
CONSOLIDATED
FINANCIALPERFORMANCE
11
11/15/15
www.apollohospitals.com
11
ConsolidatedFinancialPerformance Total
IncomefromOperations
Add:ShareofJVs
TotalRevenues
EBITDA
margin(%)
EBIT
margin(%)
ProfitAfterTax
TotalDebt
Cash&Cashequivalents(includes
investmentinliquidfunds)
Standalonefinancials
TotalDebt
Cash&Cashequivalents(includes
investmentinliquidfunds)
Q2FY15
12,350
800
13,150
1,925
14.6%
1,380
10.5%
881
Q2FY16
14,632
894
15,526
2,120
13.7%
1,515
9.8%
1,095
yoy(%)
18.5%
11.8%
18.1%
10.1%
98bps
9.8%
74bps
24.3%
(` mio)
H1FY15
23,627
1,548
25,175
3,656
14.5%
2,590
10.3%
1,676
H1FY16
28,013
1,712
29,725
4,095
13.8%
2,937
9.9%
1,892
23,990
KeyHighlights
yoy(%)
18.6%
10.6%
18.1%
12.0%
75bps
13.4%
41bps
12.9%
Revenuegrowthof18.1%from
` 25,175mioinH1FY15to` 29,725
mioinH1FY16
ConsolidatedEBITDAgrewby12.0%
ConsolidatedEBITgrewby13.4%
ConsolidatedPATwasat` 1,892mio
inH1FY16
4,470
20,275
3,277
BasisofconsolidationintheAppendix(page23)
JVsincludeAhmedabad50%,Kolkata50%,PETCT 50%,ApolloMunich 10.23%,ApolloLavasa 37.50%,FutureParkingPvtLtd 49%,ApokosRehabPvtLtd50%
Previousyearfigureshavebeenreworked/regrouped/rearrangedandreclassifiedwherevernecessarytoconformtotherequirementofrevisedScheduleVIformat
12
11/15/15
www.apollohospitals.com
1of2
12
H1FY16
H1FY15
Revenue
EBITDAR
margin(%)
EBITDA
margin(%)
EBIT
margin(%)
Revenue
EBITDAR
margin(%)
EBITDA
margin(%)
EBIT
margin(%)
YOYGrowth
RevenueGrowth
EBITDARGrowth
EBITDAGrowth
EBITGrowth
13
11/15/15
www.apollohospitals.com
Healthcare
New
services
Hospitals
(Existing)
16,240
1,407
4,181
77
25.7%
5.5%
3,899
44
24.0%
3,115
247
19.2%
15,389
767
3,788
26
24.6%
3.3%
3,529
40
22.9%
2,743
142
17.8%
5.5%
10.4%
10.5%
13.6%
83.4%
202.1%
SAP
Munich
11,032
766
6.9%
403
3.7%
306
2.8%
8,234
523
6.4%
263
3.2%
168
2.0%
415
12
2.9%
7
1.8%
2
0.5%
364
10
2.7%
4
1.1%
0
0.1%
34.0%
46.2%
53.2%
82.0%
14.1%
21.1%
77.3%
AHLL
(incl
Cradle)
632
67
171
240
420
10
100
180
50.4%
(` mio)
2of2
KeyHighlights
Consol
29,725
4,969
16.7%
4,095
13.8%
2,937
9.9%
25,175
4,337
17.2%
3,656
14.5%
2,590
10.3%
Healthcareservice(existing)EBITDA
marginsincreasedfrom22.9%inH1FY
15to24.0%inH1FY16
SAPEBITDAof` 403mio(3.7%margin)
inH1FY16ascomparedto` 263mio
(3.2%margin)inH1FY15
AHLL Cradle&Clinicsreportedan
EBITDAlossof ` 171mioascompared
tolossof` 100mioinH1FY15
18.1%
14.6%
12.0%
13.4%
13
OPERATIONALPERFORMANCE
HOSPITALS
14
11/15/15
www.apollohospitals.com
14
OperationalPerformance Hospitals
(` mio)
AHELStandaloneHospitals
Total(5)
Particulars
Chennaicluster
Significant
subs/JVs/associates(2)
Others(1)
Hyderabadcluster
H1FY15 H1FY16 yoy(%) H1FY15 H1FY16 yoy(%) H1FY15 H1FY16 yoy(%) H1FY15 H1FY16 yoy(%) H1FY15 H1FY16 yoy(%)
No.ofOperatingbeds
Inpatientvolume
(3)
Outpatientvolume
6,073
6,368
1,342
1,505
44,489
930
930
1,694
1,814
47,650
14.0%
2,107
2,119
67,933
177,540 186,816
5.2%
40,825
9.0%
26,966
25,695
4.7%
41,816
68,982
1.5%
623,497 667,863
7.1%
84,433
83,536
1.1%
5.2%
InpatientALOS(days)
4.40
4.15
4.25
3.93
4.13
4.03
4.83
4.40
4.34
4.17
BedOccupancyRate(%)
70%
67%
71%
63%
65%
61%
65%
63%
76%
74%
Inpatientrevenue(` mio)
NA
NA
4,479
5,009
11.8%
2,000
2,124
6.2%
2,590
2,952
14.0%
6,590
7,062
7.2%
Outpatientrevenue(` mio)
NA
NA
1,585
1,857
17.2%
445
495
11.0%
455
546
19.9%
1,268
1,444
13.8%
25,155
27,933
34,924
39,315
12.6%
21,965
25,254
15.0%
15,068
16,667
10.6%
26,675
29,581
10.9%
NA
NA
6,063
6,866
13.2%
2,445
2,618
7.1%
3,045
3,498
14.9%
7,858
8,506
8.3%
(4)
ARPOB(` /day)
TotalNetRevenue(` mio)(4)
11.0%
Chennai&Hyderabadclusters
Chennaiclusterrevenuegrowthof13.2%
Revenuegrowthof7.1%inHyderabad
Others Revenue growth(14.9%) Inpatientrevenuegrowth(14.0%).19.9%
growthinOPRevenues.
SignificantSubsidiary/JV&AssociateHospitals Revenuegrowthof8.3%.
13%yoygrowthinBangalore&11%yoygrowthinAhmedabadand6%yoy
growthinKolkata.
Notes:
(1)OthersincludeMadurai,Karur,Karaikudi,Trichy,Mysore,Vizag,Karimnagar,Bilaspur,Bhubaneswar,Jayanagar&
Nashik.
(2) SignificantHospitalJVs/Subs/Associatesare Ahmedabad,Bangalore,Kolkata,Kakinada,Delhi&Indore(full
revenuesshownintableabove).
(3) OutpatientvolumerepresentsNewRegistrationsonly.
(4) ARPOBandNetRevenueisnetofdoctorfees.
(5) RevenuesundertheheadTotalhavenotbeenprovidedasConsolidatedactualresultswilldifferfromtotaldue
toproportionate consolidation.
*Inpatientvolumesarebasedondischarges.
Previousyearfinancialandoperationalnumbershavebeenregroupedandreclassifiedwherevernecessarytoconformwithcurrentyearclassificationandfullyearauditednumbers.
15
11/15/15
www.apollohospitals.com
15
OPERATIONALPERFORMANCE
STANDALONEPHARMACY
16
11/15/15
www.apollohospitals.com
16
OperationalPerformance StandalonePharmacy
Batch
Particulars
NoofStores
Upto
Revenue/store
FY08Batch
EBITDA/store
EBITDAMargin%
NoofStores
Revenue/store
FY09Batch
EBITDA/store
EBITDAMargin%
NoofStores
Revenue/Store
FY10Batch
EBITDA/store
EBITDAMargin%
TotalRevenues
TotalSAP(ExcludingHetero) EBITDA
EBITDAMargin%
NoofStores
Revenue/store
Hetero
EBITDA/store
EBITDAMargin%
No.OfStore
Revenue/Store
EBITDA/Store
Total
EBITDAMargin%
TotalRevenues
EBITDA
EBITDAMargin%
Capex(RsMio)
CapitalEmployed(RsMio)
TotalROCE%
TotalNo.ofEmployees
17
11/15/15
www.apollohospitals.com
Q2FY15
427
3.34
0.19
5.7%
191
3.06
0.10
3.3%
180
2.67
0.11
4.3%
4,372
143
3.3%
1,717
2.54
0.08
3.3%
4,372
143
3.3%
71
4,628
8.3%
Q2FY16
421
3.77
0.25
6.6%
187
3.56
0.18
5.0%
174
3.12
0.18
5.7%
5,515
224
4.1%
299
1.05
0.04
3.5%
2,217
2.63
0.10
3.6%
5,831
213
3.7%
108
6,000
10.9%
yoy(%)
12.9%
30.8%
91bps
16.3%
77.7%
172bps
17.0%
53.6%
135bps
26.1%
57.1%
80bps
3.4%
14.7%
36bps
33.4%
49.4%
39bps
H1FY15
427
6.43
0.37
5.8%
191
5.85
0.20
3.4%
180
5.12
0.23
4.5%
8,234
263
3.2%
1,717
4.79
0.15
3.2%
8,234
263
3.2%
119
4,628
7.3%
11,699
(` mio)
H1FY16
421
7.31
0.48
6.6%
187
6.88
0.33
4.8%
174
6.01
0.33
5.5%
10,564
419
4.0%
299
1.56
0.06
3.6%
2,217
4.98
0.18
3.6%
11,032
403
3.7%
169
6,000
10.2%
13,731
yoy(%)
KeyHighlights
13.7%
29.5%
80bps
Revenuesat` 11,032mio,growthof34%
17.7%
66.7%
140bps
EBITDAof` 403mioinH1FY16as
comparedto` 263mioinH1FY15,growth
of53.2%
EBITDAmarginsof3.7%inH1FY16
ascomparedto3.2%inH1FY15
17.4%
43.9%
101bps
28.3%
59.5%
78bps
ExcludingtheHeteronetworkofstores,
Revenuegrowthwas28%andEBITDA
growthwas59%,EBITDAmarginof4.0%
inH1FY16
LFL(Likeforlike)Revenueperstore
growthforpreFY2010batchofstores
inH1FY16is15.4%(yoy)andEBITDA
perstoregrowthis38.1%(yoy).EBITDA
marginof5.9%inH1FY16ascompared
to5.0%inH1FY15
3.8%
18.1%
44bps
34.0%
53.2%
46bps
ROCEinH1FY16at10.2%ascompared
to7.3%inH1FY15
Grossadditionof117storesandclosed26storesinH1FY16
Netadditionof91stores.
No.ofstoresason30th Sep2015is2,217
17
UPDATEONPROJECTS
18
11/15/15
www.apollohospitals.com
18
KeyHospitalExpansionPlan&UpdateonExecution
Location
CoD*
(` mio)
TotalEstimated
ProjectCost(INR
TypeofHospital No.OfBeds
mn)
KeyHighlights
Weareinthefinalstagesofour
currentexpansionplans
AdditioninFY16
NaviMumbai
FY16
SuperSpecialty
400
5,250
NorthBangalore
FY16
SuperSpecialty
180
925
Vizag
FY16
SuperSpecialty
250
1,494
Indore(Expansion)
FY16
SuperSpecialty
65
280
895
7,949
175
2,000
SubTotal
1,300bedsin9locationscommissioned
inthelast24months Vanagaram260,
Jayanagar140,Trichy200,Nashik125,
WomenandChild OMR60,Indore120,
Nellore190,Perungudi150,Women&
Child SMR50
Toadd895bedsin3locationsinFY16
NorthBangalore180,NaviMumbai
400,Indore65&Vizag250
AdditioninFY19
SouthChennai
FY19
Proton
FY19
Byculla,Mumbai
FY19
SubTotal
Total
SuperSpecialty
4,200
SuperSpecialty
300
1,400
475
7,600
1,370
15,549
Toaddanother475bedsinFY19 South
Chennai175,SouthMumbai300.
Focus now is on operationalising the
new capacity and growing and
consolidating our leadership position in
these markets in the next 18 24
months
ThetotalCAPEXestimatedforthisexpansionplanisRs1,555crore.OfthisInvestmentofRs724crorealreadymade.Balancewillbeinvestedbya
mixofinternalaccrualsandtheproposedrightsIssue.
19
Expecteddateofcompletion
11/15/15
www.apollohospitals.com
19
UPDATEONNON
HOSPITALJVS
20
11/15/15
www.apollohospitals.com
20
UpdateonnonhospitalJVs
(` mio)
KeyHighlights
ApolloMunichHealthInsuranceCoLtd
Particulars
TotalIncome
EBITDA
margin(%)
ProfitafterTax
margin(%)
Q2FY15
1,799
34
1.9%
16
0.9%
Q2FY16
2,093
78
3.7%
48
2.3%
yoy(%)
16.3%
127.6%
181bps
192.7%
138bps
H1FY15
3,557
40
1.1%
2
0.1%
H1FY16
4,058
71
1.8%
20
0.5%
yoy(%)
14.1%
77.3%
63bps
DuringH1FY16,thecompanyachieved
aGrossWrittenPremium(GWP)of
` 4,051mioagainstaGWPof` 3,001
mioinH1FY15
725.9%
43bps
EBITDAof` 71mioinH1FY16as
comparedtoEBITDAof` 40mioinH1
FY15
PATof ` 20mioinH1FY16in
comparisonto ` 2mioin
H1FY15.
Theincurredclaimlossratiowasat
66.5%inH1FY16
TheAssetsunderManagementstood
at` 7,162mioasonSep30,2015
TheCompanynowhas85officesacross
thecountry
Previousyearfigureshavebeenreworked/regrouped/rearrangedandreclassifiedwherevernecessarytoconformtotherequirementofrevisedScheduleVIformat
21
11/15/15
www.apollohospitals.com
21
22
11/15/15
www.apollohospitals.com
22
Appendix:BasisofConsolidation
AHELStandalone
Location
Description
AHEL
Ownership
Subsidiaries
Location
ChennaiMain
Chennai
Hospital
SamudraHealthcareEnterprisesLtd.
Kakinada
ASH Chennai
Chennai
Hospital
ApolloHospitals(UK)Ltd
Tondiarpet Chennai
Chennai
Hospital
ImperialHospitalandResearchCentreLtd.
FirstMed Chennai
Chennai
Hospital
ApolloChildren'sHospital
Chennai
ApolloSpecialty,Vanagaram
Chennai
Description
AHEL
Ownership
Hospital
100.0%
UK
Hospital
100.0%
Bangalore
Hospital
90.0%
PinakiniHospitalsLtd.
Nellore
Hospital
79.4%
Hospital
UniqueHomeHealthcareLimited
Chennai
ParamedicalServices
100.0%
Hospital
ApolloHealthandLifestyleLtd.
Hyderabad
ApolloClinics
100.0%
Women&Child,OMR
Chennai
Hospital
ABMedicalCentresLimited
Chennai
Infrastructure
100.0%
ASHPerungudi
Chennai
Hospital
WesternHospitalsCorporationPvtLtd
Belapur
Hospital
100.0%
Women&Child,ShafeeMohammedRoad
Chennai
Hospital
SapienBiosciensesPvtLtd
Hyderabad
Biobankingtissues
70.0%
Madurai
Madurai
Hospital
ApolloRajshreeHospital
Indore
Hospital
57.7%
Karur
Karur
Hospital
Karaikudi
Karaikudi
Hospital
Trichy
Trichy
Hospital
Nellore
Nellore
Hospital
100.0%
JVs
Location
ApolloHospitalsInternationalLtd.
Description
Ahmedabad
Hospital
50.0%
ApolloGleneaglesHospitalsLtd.
Kolkata
Hospital
50.0%
ApolloGleneaglesPETCTPvt.Ltd.
Hyderabad
Hospital
50.0%
Hyderabad
Hyderabad
Hospital
ApolloMunichHealthInsuranceCompanyLtd
Bilaspur
Bilaspur
Hospital
ApolloLavasaHealthCorporationLtd
Maharashtra Hospital
37.5%
HealthInsurance
10.2%
Mysore
Mysore
Hospital
FutureParkingPvtLtd
Chennai
Infrastructure
49.0%
Vizag
Vizag
Hospital
ApoKosRehabPvtLtd
Hyderabad
RehabCentre
50.0%
KarimNagar
KarimNagar
Hospital
Bhubaneswar
Bhubaneswar
Hospital
Jayanagar
Bangalore
Hospital
Nashik
Nashik
Hospital
23
11/15/15
www.apollohospitals.com
Associates
Location
IndraprasthaMedicalCorporationLtd.
FamilyHealthPlanLtd.
StemcyteIndiaTherapauticsPvtLtd
Delhi,Noida
Ahmedabad
23
Description
Hospital
TPA,HealthInsurance
StemcellBanking
22.0%
49.0%
24.5%
Hospitals UnderstandingKeyOperatingMetrics
Description
24
Formula/Calculation
KeyDriver
OperatingBeds
Numberofoperatingbeds
Occupancy
InpatientBedDays
InpatientBedDaysBilled
ALOS
AverageLengthofStayper
Inpatient
InPatientBedDays/
InPatientAdmissions
CaseMix/Typeofprocedures
Leveragetechnologyandquality
ofclinicalcaretoshortenstay
ARPOB/day
AverageRevenuePer
OccupiedBedDay
(IPRevenue*+
OPRevenue+HospitalBased
PharmacyRevenue)/
IPBedDays
CaseMix/Typeofprocedures
Betterutilizationofoperational
theatres,medicalequipment
Pricing
Contribution
Contribution
Revenue Variablecosts
Purchasingefficiency
Operatingefficiency
Projectexecution
CapitalExpenditure
Brand
Doctorreputation
Qualityofoutcomes
Competition
ApollodoesnotincludeconsultantfeeinitsIPRevenuereportingasconsultantsatApollooperateonafeeforservicemodel.
11/15/15
www.apollohospitals.com
24
THANKYOU
25
11/15/15
www.apollohospitals.com
25